blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2213297

EP2213297 - Staphylococcus aureus antigenic polypeptides [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.10.2015
Database last updated on 24.04.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): BG, CY, HU, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
Absynth Biologics Limited
131 Mount Pleasant
Liverpool Science Park, Innovation Centre 1
Liverpool L3 5TF / GB
[2014/15]
Former [2010/31]For all designated states
Absynth Biologics Ltd
40 Leavygreave Road
Sheffield S3 7RD / GB
Inventor(s)01 / Foster, Simon J.
Cedar Croft
Higger Lane
Hathersage West Yorkshire S32 1AW / GB
02 / Garcia Lara, Jorge
9 Midvale Avenue
Sheffield S6 3HJ / GB
 [2014/51]
Former [2010/31]01 / Foster, Simon J.
Cedar Croft Higger Lane
Hathersage West Yorkshire S32 1AW / GB
02 / Garcia Lara, Jorge
9 Midvale Avenue
Sheffield S6 3HJ / GB
Representative(s)Docherty, Robert Charles, et al
Symbiosis IP Limited
York Biotech Campus
Office 14FA05
Sand Hutton
York, YO41 1LZ / GB
[N/P]
Former [2014/51]Docherty, Robert Charles, et al
Symbiosis IP
106 Hepworth Green
York YO31 7TQ / GB
Former [2010/47]Docherty, Robert Charles, et al
Symbiosis IP Limited Apollo House Eboracum Way
Heworth Green, York YO31 7RE / GB
Former [2010/31]Docherty, Robert Charles
Gilholm Harrison Limited Marlborough House Westminster Place York Business Park
Nether Poppleton, York YO26 6RW / GB
Application number, filing date10075018.108.03.2006
[2010/31]
Priority number, dateGB2005000594923.03.2005         Original published format: GB 0505949
[2010/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2213297
Date:04.08.2010
Language:EN
[2010/31]
Type: B1 Patent specification 
No.:EP2213297
Date:17.12.2014
Language:EN
[2014/51]
Type: B8 Corrected title page of specification 
No.:EP2213297
Date:28.01.2015
[2015/05]
Search report(s)(Supplementary) European search report - dispatched on:EP05.07.2010
ClassificationIPC:A61K39/07, A61K39/085, A61K39/395, C07K7/06, C07K14/31
[2010/31]
CPC:
C07K16/1271 (EP,US); A61K39/07 (EP,US); A61K39/085 (EP,US);
A61K39/40 (US); A61P1/04 (EP); A61P11/00 (EP);
A61P17/00 (EP); A61P21/00 (EP); A61P27/16 (EP);
A61P31/00 (EP); A61P31/04 (EP); A61P31/06 (EP);
A61P37/04 (EP); A61P7/00 (EP); C07K14/31 (EP,US);
C07K14/32 (EP,US); C07K16/1278 (EP,US); A61K38/00 (EP,US);
Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/31]
TitleGerman:Staphylococcus aureus antigen Polypeptiden[2010/31]
English:Staphylococcus aureus antigenic polypeptides[2010/31]
French:Polypeptides antigéniques de staphylococcus aureus[2010/31]
Examination procedure21.01.2011Amendment by applicant (claims and/or description)
21.01.2011Examination requested  [2011/10]
15.06.2011Despatch of a communication from the examining division (Time limit: M06)
13.12.2011Reply to a communication from the examining division
09.08.2012Despatch of a communication from the examining division (Time limit: M06)
12.02.2013Reply to a communication from the examining division
26.07.2013Despatch of a communication from the examining division (Time limit: M04)
02.10.2013Reply to a communication from the examining division
22.07.2014Communication of intention to grant the patent
05.11.2014Fee for grant paid
05.11.2014Fee for publishing/printing paid
05.11.2014Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP06710041.2  / EP1863525
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060710041) is  01.04.2008
Opposition(s)18.09.2015No opposition filed within time limit [2015/48]
Fees paidRenewal fee
13.01.2010Renewal fee patent year 03
13.01.2010Renewal fee patent year 04
13.01.2010Renewal fee patent year 05
01.02.2011Renewal fee patent year 06
02.02.2012Renewal fee patent year 07
19.02.2013Renewal fee patent year 08
05.03.2014Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.03.2006
AT17.12.2014
BE17.12.2014
BG17.12.2014
CY17.12.2014
CZ17.12.2014
EE17.12.2014
FI17.12.2014
LT17.12.2014
LV17.12.2014
MC17.12.2014
PL17.12.2014
RO17.12.2014
SI17.12.2014
SK17.12.2014
TR17.12.2014
IE08.03.2015
LU08.03.2015
GR18.03.2015
IS17.04.2015
PT17.04.2015
[2017/39]
Former [2016/24]AT17.12.2014
BE17.12.2014
CZ17.12.2014
EE17.12.2014
FI17.12.2014
LT17.12.2014
LV17.12.2014
MC17.12.2014
PL17.12.2014
RO17.12.2014
SI17.12.2014
SK17.12.2014
IE08.03.2015
LU08.03.2015
GR18.03.2015
IS17.04.2015
PT17.04.2015
Former [2016/12]AT17.12.2014
CZ17.12.2014
EE17.12.2014
FI17.12.2014
LT17.12.2014
LV17.12.2014
MC17.12.2014
PL17.12.2014
RO17.12.2014
SI17.12.2014
SK17.12.2014
IE08.03.2015
LU08.03.2015
GR18.03.2015
IS17.04.2015
PT17.04.2015
Former [2016/07]AT17.12.2014
CZ17.12.2014
EE17.12.2014
FI17.12.2014
LT17.12.2014
LV17.12.2014
MC17.12.2014
PL17.12.2014
RO17.12.2014
SK17.12.2014
IE08.03.2015
LU08.03.2015
GR18.03.2015
IS17.04.2015
PT17.04.2015
Former [2015/47]AT17.12.2014
CZ17.12.2014
EE17.12.2014
FI17.12.2014
LT17.12.2014
LV17.12.2014
MC17.12.2014
PL17.12.2014
RO17.12.2014
SK17.12.2014
LU08.03.2015
GR18.03.2015
IS17.04.2015
PT17.04.2015
Former [2015/46]AT17.12.2014
CZ17.12.2014
EE17.12.2014
FI17.12.2014
LT17.12.2014
LV17.12.2014
MC17.12.2014
PL17.12.2014
RO17.12.2014
SK17.12.2014
GR18.03.2015
IS17.04.2015
PT17.04.2015
Former [2015/38]AT17.12.2014
CZ17.12.2014
EE17.12.2014
FI17.12.2014
LT17.12.2014
LV17.12.2014
PL17.12.2014
RO17.12.2014
SK17.12.2014
GR18.03.2015
IS17.04.2015
PT17.04.2015
Former [2015/37]CZ17.12.2014
EE17.12.2014
FI17.12.2014
LT17.12.2014
LV17.12.2014
PL17.12.2014
RO17.12.2014
SK17.12.2014
GR18.03.2015
PT17.04.2015
Former [2015/36]CZ17.12.2014
EE17.12.2014
FI17.12.2014
LT17.12.2014
LV17.12.2014
RO17.12.2014
GR18.03.2015
PT17.04.2015
Former [2015/35]EE17.12.2014
FI17.12.2014
LT17.12.2014
LV17.12.2014
GR18.03.2015
PT17.04.2015
Former [2015/24]FI17.12.2014
LT17.12.2014
LV17.12.2014
GR18.03.2015
Former [2015/23]FI17.12.2014
LT17.12.2014
Former [2015/20]LT17.12.2014
Documents cited:Search[XI]WO0013694  (SMITHKLINE BEECHAM CORP [US]) [X] 1-8,10,12-14 * abstract * * page 12, line 29 - page 14, line 5 * * page 19, line 12 - page 20, line 33 * * page 27, line 32 - page 30, line 5 * * page 40, line 14 - page 41, line 2 * * claims 3, 4 * * sequences 1, 2 * [I] 9,11,15;
 [XI]WO02094868  (CHIRON SPA [IT], et al) [X] 1-10,12-15 * abstract * * page 3, line 7 - line 18 * * page 8, line 25 - page 20, line 34 * * page 20, line 35 - page 22, line 30 * * page 23, line 1 - page 24, line 16 * * claims 1, 4, 6, 11-15 * [I] 11;
 [XI]WO03083099  (AFFINIUM PHARM INC [CA], et al) [X] 1-10,12-14 * page 42, line 28 - line 33 * * Antibodies; page 106 - page 111 * * Vaccines; page 125 - page 127 * * sequences 13-16 * [I] 11,15;
 [XI]WO0170955  (ELITRA PHARMACEUTICALS INC [US], et al) [X] 7,8 * example 7 * * sequences 4672, 5727,8060, 12158 * [I] 1-6,9-15;
 WO02077183  [ ] (ELITRA PHARMACEUTICALS INC [US], et al) [ ] * claims 25, 32 * * sequences 7974, 44158 * * example 12 *
 [XI]  - Wang et al., "Protein encoded by Prokaryotic essential gene 1761", Geneseq, (20030619), Database accession no. ABU16234, URL: EBI, XP002586213 [X] 7,8 * the whole document * [I] 1-6,9-15
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.